COVID-19 vaccines are chance at salvation, financial and beyond, for drug makers

New York Times

13 October 2020 - Big profits beckon for pharmaceutical companies, which are already using their work on vaccines to fight efforts in Washington to curb drug prices.

For a long time, drug makers have been the most hated industry in America. Companies are blamed for gouging prices on lifesaving drugs and enriching themselves through the opioid crisis, among other sins.

Now, with pharmaceutical companies racing to find vaccines to end the coronavirus pandemic, the industry is hoping to redeem itself in the public’s mind.

Read New York Times article

Michael Wonder

Posted by:

Michael Wonder